Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome.
Saved in:
| Title: | Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome. |
|---|---|
| Authors: | Oliveira E; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Costa ES; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Ciudad J; Translational and Clinical Research Program, Centro de Investigación del Cáncer and IBMCC (CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain., Gaipa G; M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy., Sedek Ł; Department of Microbiology and Immunology, Medical University of Silesia in Katowice (SUM), 41-808 Zabrze, Poland., Barrena S; Translational and Clinical Research Program, Centro de Investigación del Cáncer and IBMCC (CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain., Szczepanski T; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice (SUM), 41-800 Zabrze, Poland., Buracchi C; M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy., Silvestri D; Center of Biostatistics for Clinical Epidemiology, Department of Health Science, University of Milano-Bicocca, 20126 Milano, Italy., Siqueira PFR; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Mello FV; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Torres RC; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Oliveira LMR; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Fay-Neves IVC; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Sonneveld E; Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, Dr. Molewaterplein 80, 3015 CN Rotterdam, The Netherlands., Mejstrikova E; Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, 15006 Prague, Czech Republic., Ribera JM; Institut Català d'Oncologia-Hospital Germans Trias I Pujol, Josep Carreras Research Institute Badalona, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain., Conter V; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, 20900 Monza, Italy., Schrappe M; Department of Pediatric Hematology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany., van Dongen JJM; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Land MGP; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and IBMCC (CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain. |
| Corporate Authors: | EuroFlow Consortium |
| Source: | Cancers [Cancers (Basel)] 2022 Jun 23; Vol. 14 (13). Date of Electronic Publication: 2022 Jun 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers14133088 |
